09:55 AM EST - Oncolytics Biotech Inc. : Announced its financial results and operational highlights for the quarter and year ended December 31, 2018. On that date, the company reported $13.7 million in cash and cash equivalents. The net loss for the fourth quarter of 2018 was $4.8 million and $17.0 million for the year 2018, compared to $4.7 million in the fourth quarter 2017 and $15.6 million for the year 2017, which equates to a loss of $1.06 per share in 2018 compared to a net loss of $1.12 per share in 2017, on a consolidated basis. Oncolytics Biotech Inc.
shares T.ONC are trading up $0.01 at $2.51.
